Latest California Healthline Stories
KHN Conversation On Overtreatment
Physicians estimate that 21 percent of medical care is unnecessary — a problem that costs the health care system at least $210 billion a year. KHN hosted a forum on how too much medicine can cause harm.
Travel Ban Spotlights U.S. Dependence On Foreign-Born Doctors
One in four doctors practicing in the U.S. is an international medical doctor. Many foreign-born doctors practice in parts of the country where there are doctor shortages.
HHS Pick Price Made ‘Brazen’ Stock Trades While His Committee Was Under Scrutiny
With federal investigators bearing down on his committee, Rep. Tom Price, who is in line to be secretary of HHS, showed little restraint in investing in health companies.
Trump’s Immigration Ban Fuels Fear For Young Doctors Whose Jobs May Be In Limbo
With announcements of placements in residencies expected in March, medical education groups and hospitals say they’re unsure how to proceed.
Women Fear Drug They Used To Halt Puberty Led To Health Problems
Despite questions about Lupron’s lasting side effects and minimal study into its safety, the FDA sped approval of the drug to market. Years later, some young women are still living with the consequences.
Democrats Say Cabinet Choice Tom Price ‘Misled’ The Public. Here’s What We Know.
Concerns over U.S. Rep. Tom Price’s answers about stock trades led Senate Democrats to boycott a committee vote that would have moved his nomination to the Senate floor.
Getting Patients Hooked On An Opioid Overdose Antidote, Then Raising The Price
The device, known as an Evzio, administers just enough naloxone to stabilize someone who has overdosed on drugs. But its manufacturer, Kaleo, may be positioning itself to find profits in a dire health care crisis.
Orphan Drugs Interactive Database
Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.
Video: Former U.S. Rep. Henry Waxman Shares Deep Concerns About Orphan Drugs
The former Congressman championed the Orphan Drug Act decades ago but now he fears it’s being manipulated to make money.
For Some Patients In Marketplace Plans, Access To Cancer Centers Is Elusive
In a number of states, including big ones such as New York and Texas, leading cancer centers aren’t included in insurers’ provider networks.